One dose of an MF59-adjuvanted pandemic A/H1N1 vaccine recruits pre-existing immune memory and induces the rapid rise of neutralizing antibodies (Q30415722)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	One dose of an MF59-adjuvanted pandemic A/H1N1 vaccine recruits pre-existing immune memory and induces the rapid rise of neutralizing antibodies	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

21 June 2017

One dose of an MF59-adjuvanted pandemic A/H1N1 vaccine recruits pre-existing immune memory and induces the rapid rise of neutralizing antibodies (English)

1 reference

Europe PubMed Central

21 June 2017

0 references

1 reference

based on heuristic

inferred from title

Emanuele Montomoli

14

object named as

Emanuele Montomoli

1 reference

Europe PubMed Central

21 June 2017

16

object named as

Rino Rappuoli

1 reference

Europe PubMed Central

21 June 2017

author name string

Elisa Faenzi

1

1 reference

Europe PubMed Central

21 June 2017

Luisanna Zedda

2

1 reference

Europe PubMed Central

21 June 2017

Monia Bardelli

3

1 reference

Europe PubMed Central

21 June 2017

Fabiana Spensieri

4

1 reference

Europe PubMed Central

21 June 2017

Erica Borgogni

5

1 reference

Europe PubMed Central

21 June 2017

Gianfranco Volpini

6

1 reference

Europe PubMed Central

21 June 2017

Francesca Buricchi

7

1 reference

Europe PubMed Central

21 June 2017

Franco Laghi Pasini

8

1 reference

Europe PubMed Central

21 June 2017

Pier Leopoldo Capecchi

9

1 reference

Europe PubMed Central

21 June 2017

Fabio Montanaro

10

1 reference

Europe PubMed Central

21 June 2017

Riccardo Belli

11

1 reference

Europe PubMed Central

21 June 2017

Maria Lattanzi

12

1 reference

Europe PubMed Central

21 June 2017

Simona Piccirella

13

1 reference

Europe PubMed Central

21 June 2017

Syed Sohail Ahmed

15

1 reference

Europe PubMed Central

21 June 2017

Giuseppe Del Giudice

17

1 reference

Europe PubMed Central

21 June 2017

Oretta Finco

18

1 reference

Europe PubMed Central

21 June 2017

Flora Castellino

19

1 reference

Europe PubMed Central

21 June 2017

Grazia Galli

20

1 reference

Europe PubMed Central

21 June 2017

language of work or name

0 references

publication date

19 April 2012

1 reference

Europe PubMed Central

21 June 2017

1 reference

Europe PubMed Central

21 June 2017

30

1 reference

Europe PubMed Central

21 June 2017

4086-4094

1 reference

Europe PubMed Central

21 June 2017

27

1 reference

Europe PubMed Central

21 June 2017

Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.020

7 January 2021

Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.020

7 January 2021

Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.020

7 January 2021

Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.020

7 January 2021

Responses to 2009 H1N1 vaccine in children 3 to 17 years of age.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.020

7 January 2021

Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.020

7 January 2021

Response to a monovalent 2009 influenza A (H1N1) vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.020

7 January 2021

A novel influenza A (H1N1) vaccine in various age groups.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.020

7 January 2021

Response to 2009 pandemic influenza A (H1N1) vaccine in HIV-infected patients and the influence of prior seasonal influenza vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.020

7 January 2021

Seasonal H1N1 2007 influenza virus infection is associated with elevated pre-exposure antibody titers to the 2009 pandemic influenza A (H1N1) virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.020

7 January 2021

Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.020

7 January 2021

Assessment of seasonal influenza A virus-specific CD4 T-cell responses to 2009 pandemic H1N1 swine-origin influenza A virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.020

7 January 2021

Cutting edge: CD4 T cells generated from encounter with seasonal influenza viruses and vaccines have broad protein specificity and can directly recognize naturally generated epitopes derived from the live pandemic H1N1 virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.020

7 January 2021

Structural Basis of Preexisting Immunity to the 2009 H1N1 Pandemic Influenza Virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.020

7 January 2021

Antibody response against heterogeneous circulating influenza virus strains elicited by MF59- and non-adjuvanted vaccines during seasons with good or partial matching between vaccine strain and clinical isolates.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.020

7 January 2021

Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.020

7 January 2021

Durability of antibody responses after receipt of the monovalent 2009 pandemic influenza A (H1N1) vaccine among HIV-infected and HIV-uninfected adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.020

7 January 2021

Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.020

7 January 2021

Efficacy of vaccination with different combinations of MF59-adjuvanted and nonadjuvanted seasonal and pandemic influenza vaccines against pandemic H1N1 (2009) influenza virus infection in ferrets

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.020

7 January 2021

Multiple infections with seasonal influenza A virus induce cross-protective immunity against A(H1N1) pandemic influenza virus in a ferret model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.020

7 January 2021

Seasonal influenza infection and live vaccine prime for a response to the 2009 pandemic H1N1 vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.020

7 January 2021

T-cell quality in memory and protection: implications for vaccine design

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.020

7 January 2021

Healthy human subjects have CD4+ T cells directed against H5N1 influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.020

7 January 2021

Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.020

7 January 2021

Complement-dependent lysis of influenza a virus-infected cells by broadly cross-reactive human monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.020

7 January 2021

Partial protection of seasonal trivalent inactivated vaccine against novel pandemic influenza A/H1N1 2009: case-control study in Mexico City

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.020

7 January 2021

Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.020

7 January 2021

Clinical and epidemiologic characteristics of an outbreak of novel H1N1 (swine origin) influenza A virus among United States military beneficiaries

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.020

7 January 2021

Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.020

7 January 2021

Identifiers

10.1016/J.VACCINE.2012.04.020

1 reference

Europe PubMed Central

21 June 2017

1 reference

Europe PubMed Central

21 June 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30415722&oldid=1588510973"